Grufity logo
Grufity logo

Latest Bellevue Group AG Stock Portfolio

$4.75Billion | No. of Holdings #148

Bellevue Group AG Performance

2026 Q2+8.16%
YTD+3.11%
2025+20.44%

About Bellevue Group AG and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Bellevue Group AG reported an equity portfolio of $4.8 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Bellevue Group AG are AMGN, VRTX, ARGX. The fund has invested 6.5% of it's portfolio in AMGEN INC and 6% of portfolio in VERTEX PHARMACEUTICALS INC. <br><br> The fund managers got completely rid off EDGEWISE THERAPEUTICS INC (EWTX), INSPIRE MED SYS INC (INSP) and PENUMBRA INC (PEN) stocks. They significantly reduced their stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), BRISTOL-MYERS SQUIBB CO (BMY) and BIOGEN INC (BIIB). Bellevue Group AG opened new stock positions in AVALYN PHARMACEUTICALS INC, SPYRE THERAPEUTICS INC (AGLE) and AURA BIOSCIENCES INC (AURA). The fund showed a lot of confidence in some stocks as they added substantially to INSMED INC (INSM), UNITED THERAPEUTICS CORP DEL (UTHR) and BRIDGEBIO PHARMA INC (BBIO).
Bellevue Group AG Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$4.75Billion
  as of Aug 14, 2026

Bellevue Group AG Annual Return Estimates Vs S&P 500

Our best estimate is that Bellevue Group AG made a return of 8.16% in the last quarter. In trailing 12 months, it's portfolio return was 26.53%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
avalyn pharmaceuticals inc44,442,000
cg oncology inc35,070,000
seaport therapeutics inc23,892,000
palvella therapeutics inc ne23,687,100
spyre therapeutics inc20,413,300
hemab therapeutics hldgs inc20,201,500
parabilis medicines inc13,685,000
aura biosciences inc8,283,340
New stocks bought by Bellevue Group AG

Additions

Ticker% Inc.
insmed inc13,787
united therapeutics corp del8,976
bridgebio pharma inc4,587
alkermes plc1,255
abivax sa510
neurocrine biosciences inc417
protagonist therapeutics inc285
oruka therapeutics inc226
Additions to existing portfolio by Bellevue Group AG

Reductions

Ticker% Reduced
alnylam pharmaceuticals inc-99.53
bristol-myers squibb co-92.86
biogen inc-90.75
krystal biotech inc-83.91
tango therapeutics inc-71.08
mineralys therapeutics inc-70.2
cencora inc-66.43
pfizer inc-64.3
Bellevue Group AG reduced stake in above stock

Sold off

Ticker$ Sold
edgewise therapeutics inc-48,148,300
atrium therapeutics inc-3,517,590
inspire med sys inc-5,144,330
equinor asa-741,581
olema pharmaceuticals inc-245,165
bp plc-735,268
penumbra inc-4,028,120
jd.com inc-325,270
Bellevue Group AG got rid off the above stocks

Sector Distribution

Bellevue Group AG has about 81.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare81.9
Others18

Market Cap. Distribution

Bellevue Group AG has about 54.6% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • MID-CAP
  • UNALLOCATED
  • MEGA-CAP
  • SMALL-CAP
Category%
LARGE-CAP44
MID-CAP23.1
UNALLOCATED18
MEGA-CAP10.6
SMALL-CAP3.9

Stocks belong to which Index?

About 73.5% of the stocks held by Bellevue Group AG either belong to S&P 500 or RUSSELL 2000 index.

  • S&P 500
  • RUSSELL 2000
  • Others
Index%
S&P 50041.3
RUSSELL 200032.2
Others26.5
Top 5 Winners (%)%
HUM
humana inc
123.0 %
CNC
centene corp del
90.1 %
TVTX
travere therapeutics inc
81.0 %
RLAY
relay therapeutics inc
79.0 %
RVMD
revolution medicines inc
77.7 %
Top 5 Winners ($)$
RVMD
revolution medicines inc
116.7 M
RLAY
relay therapeutics inc
61.2 M
ARGX
argenx se
60.6 M
oruka therapeutics inc
49.9 M
KRYS
krystal biotech inc
31.7 M
Top 5 Losers (%)%
ZTS
zoetis inc
-34.0 %
TMDX
transmedics group inc
-33.2 %
BSX
boston scientific corp
-25.7 %
PODD
insulet corp
-24.4 %
SMMT
summit therapeutics inc
-22.7 %
Top 5 Losers ($)$
INSM
insmed inc
-39.9 M
REGN
regeneron pharmaceuticals
-32.5 M
BSX
boston scientific corp
-23.6 M
GILD
gilead sciences inc
-21.7 M
ISRG
intuitive surgical inc
-17.1 M

Bellevue Group AG Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Bellevue Group AG

Bellevue Group AG has 148 stocks in it's portfolio. About 42.9% of the portfolio is in top 10 stocks. INSM proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Bellevue Group AG last quarter.

$4.75BTotal Value
172Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Bellevue Group AG, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AFK
Vaneck Etf Trust

Vaneck Etf Trust

AFK
Bellevue Group AG's holding in Vaneck Etf Trust over time
0.01%5,750
$433.8K
0.01%
unchanged 0 percentunchanged
ARGX
Argenx Se

Argenx Se

ARGX
Bellevue Group AG's holding in Argenx Se over time
5.88%301,000
$279.26M
5.88%
decreased 3.83 percentreduced
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Bellevue Group AG's holding in Ascendis Pharma A/S over time
0%0.00
$0.00
0%
decreased 100 percentsold off